The indie singer-songwriter announced his diagnosis in 2023 with a photo of himself in a wheelchair Sufjan Stevens gave a ...

The self-declared “poster child of death in the music world” lost his partner and then got sick. But he’s trying to stay ...

The oral presentation highlighted the benefits of tanruprubart in improving patient outcomes compared to current standard treatments for Guillain-Barré Syndrome (GBS), which lacks FDA-approved ...

The Task Force of the European Academy of Neurology and the Peripheral Nerve Society published updated guidelines in 2024 on the diagnosis and treatment of Guillain-Barré syndrome (GBS), which ...

Sufjan Stevens was left devastated in April 2023 after his partner Evans Richardson died and he also struggled with ...

A comprehensive new study reveals that respiratory syncytial virus (RSV) vaccines provide strong protection for adults aged ...

The company’s lead investigational therapy, tanruprubart, demonstrated significant benefits over current standard care for Guillain-Barré Syndrome (GBS), a rare autoimmune disorder. At the ...

To tell it to a 20-year-old Ryan Warsofky, a defenseman from Sacred Heart University relegated to exactly zero games as a ...

Of the RSV patients aged 60 or older, 23.0% were admitted to an ICU, 31.5% had acute organ failure, and 9.8% received IMV or ...

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...